The leadership team at Valirx has a history in finance and pharmaceuticals. The team includes the current Chief Executive Officer, who was previously the Head of Chemical Biology at SEEK, and the Finance Director, who was previously the Finance Director at Innovative Physics Ltd. The team also includes the Director at Tangent Reprofiling Limited and the Chief Operating Officer at a2sp Limited. All members of the leadership team have a background in medicinal chemistry and/or organic chemistry from Loughborough University.